Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study
出版年份 2020 全文链接
标题
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-7
出版商
Informa UK Limited
发表日期
2020-11-21
DOI
10.1080/14712598.2021.1853698
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic
- (2020) S.K. Mahil et al. BRITISH JOURNAL OF DERMATOLOGY
- The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience
- (2020) P. Gisondi et al. BRITISH JOURNAL OF DERMATOLOGY
- Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID ‐19 days
- (2020) Lavinia Agra Coletto et al. Dermatologic Therapy
- Biologics for psoriasis in COVID ‐19 era: what do we know?
- (2020) M. Megna et al. Dermatologic Therapy
- Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
- (2020) Ming Zhao INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biologic therapy for psoriasis during the covid-19 outbreak is not a choice
- (2020) Federico Bardazzi et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
- (2020) Paolo Gisondi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Should biologics for psoriasis be interrupted in the era of COVID-19?
- (2020) Mark Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases?
- (2020) Ambra Di Altobrando et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
- (2020) M. Talamonti et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Reply: “Biologics for psoriasis during COVID-19 outbreak”
- (2020) Vito Di Lernia JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy
- (2020) M. Talamonti et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started